Cite
MLA Citation
Margret Merino et al.. “FDA approval summary: Crizotinib for pediatric and young adult patients with relapsed or refractory systemic anaplastic large cell lymphoma.” Pediatric blood & cancer, vol. 69, no. 8, 2022, p. n/a. http://access.bl.uk/ark:/81055/vdc_100158020481.0x000024